Phentolamine Mesylate (NV-101)

DRUG3 trials

Sponsors

Novalar Pharmaceuticals, Inc.

Conditions

Anesthesia, Dental

Phase 2

Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures

CompletedNCT00309322

Novalar Pharmaceuticals, Inc.Anesthesia, Dental

Start: 2006-03-31End: 2006-08-31Target: 150Updated: 2006-11-17

Phase 3

Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures

CompletedNCT00309361

Novalar Pharmaceuticals, Inc.Anesthesia, Dental

Start: 2006-02-28End: 2006-07-31Target: 240Updated: 2006-11-17

Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures

CompletedNCT00309335

Novalar Pharmaceuticals, Inc.Anesthesia, Dental

Start: 2006-02-28End: 2006-07-31Target: 240Updated: 2006-11-17